Strides’ generic Tamiflu approved
The Food and Drug Administration has approved Strides Pharma’s generic Tamiflu capsules (oseltamivir phosphate capsules). The drug is indicated to treat symptoms caused by the flu virus and shorten recovery time.
The Strides Shasun subsidiary said that the product has seen volume growth in the past year due to a strong flu season. IQVIA data shows a market size for generic Tamiflu of roughly $725 million for the 12 months ended April 2018. Strides said the product would be manufactured at its oral dosage facility and Bangalore.
The product will be available in 30-, 45- and 75-mg (base) dosage strengths.
The Strides Shasun subsidiary said that the product has seen volume growth in the past year due to a strong flu season. IQVIA data shows a market size for generic Tamiflu of roughly $725 million for the 12 months ended April 2018. Strides said the product would be manufactured at its oral dosage facility and Bangalore.
The product will be available in 30-, 45- and 75-mg (base) dosage strengths.